Clinical Trial: Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Icotinib Hydrochloride Tablets Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Brief Summary: 1)Preliminarily evaluate the treatment effect of Icotinib Hydrochloride Tablets on NF2; 2)Preliminarily evaluate the safety and the patient's tolerance of the treatment of Icotinib; 3)Provide an objective basis for an enlarged randomized double-blind trial.